Biochemical risk factors in angiographically established stenosis of cerebral arteries

Croatian Medical Journal

Volumn 43, Issue 6, 2002, Pages 696-701

  Vrhovski Hebrang, Danijela ^a   Flegar Meštrić, Zlata ^a   Preden Kereković, Vlatka ^a   Perkov, Sonja ^a   Hebrang, Andrija ^a   Januš, Dragutin ^a   Grga, Ante ^a  

^a University of Zagreb   (Croatia)

Author keywords

Cerebral arteries; Constriction; Homocysteine; Lipoprotein(a); Pathologic; Risk factors

Indexed keywords

ANTIOXIDANT; HOMOCYSTEINE; LIPOPROTEIN A; BIOLOGICAL MARKER; CHOLESTEROL; HOMOCYSTINE; METAL; TRIACYLGLYCEROL;

ARTICLE; BLOOD LEVEL; BRAIN ARTERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; LABORATORY TEST; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK FACTOR; STATISTICAL ANALYSIS; STENOSIS; ULTRASOUND; ADULT; AGED; BLOOD; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; CLASSIFICATION; COMPARATIVE STUDY; CROATIA; FEMALE; MALE; MIDDLE AGED; RADIOGRAPHY; STATISTICAL MODEL; STENOSIS, OCCLUSION AND OBSTRUCTION;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR DISORDERS; CHOLESTEROL; CONSTRICTION, PATHOLOGIC; CROATIA; FEMALE; HOMOCYSTINE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 0036883913     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488-96.
2. Jurgens G, Taddei-Peters WC, Koltringer P, Petek W, Chen Q, Greilberger J, et al. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 1995;26:1841-8.
3. Yoo JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998;29:2478-83.
4. Jialal I, Devaraj S. Low-density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem 1996;42:498-506.
5. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke 1993;24:965-9.
6. Pedro-Botet J, Senti M, Auguet T, Nogues X, Rubies-Prat J, Aubo C, et al. Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease. Atherosclerosis 1993;104:87-94.
7. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998;338:1042-50.
8. Stanger O, Weger M, Renner W, Konetschny R. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease. Clin Chem Lab Med 2001;39:725-33.
9. Cobbaert C, Arentsen JC, Mulder P, Hoogerbrugge N, Lindemans J. Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status. Clin Chem 1997;43:1958-64.
10. Pirillo A, Zhu W, Norata GD, Zanelli T, Barberi L, Roma P, et al. Oxidized lipoproteins and endothelium. Clin Chem Lab Med 2000;38:155-60.
11. Iskra M, Patelski J, Majewski W. Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall and serum in atherosclerosis obliterans and aneurysm. J Trace Elem Med Biol 1997;11:248-52.
12. Knight JA, editor. Free radicals, antioxidants, aging and disease. Washington (DC): AACC Press; 1999.
13. Barandier C, Tanguy S, Pucheu S, Boucher F, De Leiris J. Effect of antioxidant trace elements on the response of cardiac tissue to oxidative stress. Ann N Y Acad Sci 1999;874:138-55.
14. Hennig B, Meerarani P, Ramadass P, Toborek M, Malecki A, Slim R, et al. Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition 1999;15:744-8.
15. Vanninen R, Manninen H, Soimakallio S. Imaging of carotid artery stenosis: clinical efficacy and cost-effectiveness. AJNR Am J Neuroradiol 1995;16:1875-83.
16. Ferro L, Garza C, Hass J, Habicht JP, Himes J, editors. Physical status: the use and interpretation of antropometry. Report of a WHO Expert Committee. Geneva: WHO; 1995. Technical Report Series No.: 854.
17. Panteghini M, Pagani F. Pre-analytical, analytical and biological sources of variation of lipoprotein(a). Eur J Clin Chem Clin Biochem 1993;31:23-8.
18. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention [guideline]. Eur Heart J 1998;19:1434-503.
19. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999;131:331-9.
20. Rahil-Khazen R, Bolann BJ, Ulvik RJ. Trace element reference values in serum determined by inductively coupled plasma atomic emission spectrometry. Clin Chem Lab Med 2000;38:765-72.
21. Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B. Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol. CMAJ 2001;165:1331-3.
22. Podobnik-Šarkanji S, Demarin V, Rundek T. Impact of risk factors on the morphology of carotid artery plaques and stroke. Acta Clinica Croatica 1997;36:77-83.
23. Vrhovski-Hebrang D. Lipidi u serumu. In: Albert-Šubic N, Tadej D, editors. Reference values of clinically relevant components of blood and serum [in Croatian]. Model: population of the city of Zagreb and city area. Zagreb: Školska knjiga; 1990. p. 200-18.
24. Vrhovski-Hebrang D, Flegar-Meštrić Z, Bobetić- Vranić T, Šurina B. Lipoprotien (a) concentrations in school children and adolescents in Croatia. Coll Antropol 1999;23:79-86.
25. Fraser CG. Biological variation: from principles to practice. Washington (DC): AACC Press; 2001.
26. Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Am J Hypertens 2000;13(1 Pt 1):105-10.
27. Voutilainen S, Alfthan G, Nyýssönen K, Salonen R, Salonen JT. Association between elevated plasma total homocysteine and increased common carotid artery wall thickness. Ann Med 1998;30:300-6.
28. Rubba P, Mercuri M, Faccenda F, Iannuzzi A, Irace C, Strisciuglio P, et al. Premature carotid atherosclerosis: does it occur in both familial hypercholesterolemia and homocystinuria? Ultrasound assessment of arterial intima-media thickness and blood flow velocity. Stroke 1994;25:943-50.
29. El Kossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000;31:1889-92.
30. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001;47:887-92.
31. Dogru-Abbasoglu S, Kanbagli Ö, Bulurh H, Babalik E, Öztürk S, Aykac-Toker G, et al. Lipid peroxides and antioxidant status in serum of patients with angiographically defined coronary atherosclerosis. Clin Biochem 1999;32:671-2.
32. Mansoor MA, Bergmark C, Haswell SJ, Savage IF, Evans PH, Berge RK, et al. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 2000;46:385-91.